{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:26:54Z","timestamp":1787164014175,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"crossref","award":["UL1TR001073"],"award-info":[{"award-number":["UL1TR001073"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10620-024-08348-2","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T15:01:40Z","timestamp":1714402900000},"page":"2586-2594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-1370","authenticated-orcid":false,"given":"Ruby","family":"Greywoode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jellyana","family":"Peraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naueen A.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Schnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin H.","family":"Shadyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Wassertheil-Smoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"8348_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cgh.2007.09.016","volume":"6","author":"CN Bernstein","year":"2008","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:41\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8348_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cgh.2011.06.032","volume":"9","author":"MT Osterman","year":"2011","unstructured":"Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn\u2019s disease. Clin Gastroenterol Hepatol 2011;9:875\u2013880.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8348_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/gutjnl-2012-303285","volume":"62","author":"C Rungoe","year":"2013","unstructured":"Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut 2013;62:689\u2013694.","journal-title":"Gut"},{"key":"8348_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","volume":"8","author":"M Fumery","year":"2014","unstructured":"Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014;8:469\u2013479.","journal-title":"J Crohns Colitis"},{"key":"8348_CR5","doi-asserted-by":"crossref","unstructured":"Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12:382\u201393 e1: quiz e22.","DOI":"10.1016\/j.cgh.2013.08.023"},{"key":"8348_CR6","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/MIB.0000000000000899","volume":"22","author":"EL Barnes","year":"2016","unstructured":"Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik R, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis 2016;22:2229\u20132237.","journal-title":"Inflamm Bowel Dis"},{"key":"8348_CR7","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cgh.2018.04.031","volume":"16","author":"S Aniwan","year":"2018","unstructured":"Aniwan S, Pardi DS, Tremaine WJ, Tremaine WJ, Loftus EV. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2018;16:1607-1615.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8348_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/ibd\/izaa156","volume":"27","author":"TR Card","year":"2021","unstructured":"Card TR, Zittan E, Nguyen GC, Grainge MJ. Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease. Inflamm Bowel Dis 2021;27:629\u2013638.","journal-title":"Inflamm Bowel Dis"},{"key":"8348_CR9","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.14309\/ajg.0000000000001237","volume":"116","author":"CN Bernstein","year":"2021","unstructured":"Bernstein CN, Nugent Z, Singh H. Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol 2021;116:1476\u20131484.","journal-title":"Am J Gastroenterol"},{"key":"8348_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/ibd\/izy354","volume":"25","author":"MS Panhwar","year":"2019","unstructured":"Panhwar MS, Mansoor E, Al-Kindi SG, Sinh P et al. Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study. Inflamm Bowel Dis 2019;25:1080\u20131087.","journal-title":"Inflamm Bowel Dis"},{"key":"8348_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrgastro.2014.202","volume":"12","author":"S Singh","year":"2015","unstructured":"Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol 2015;12:26\u201335.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8348_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ibd.21417","volume":"17","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn\u2019s disease in population-based cohorts. Inflamm Bowel Dis 2011;17:471\u2013478.","journal-title":"Inflamm Bowel Dis"},{"key":"8348_CR13","doi-asserted-by":"publisher","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","volume":"8","author":"SL Kristensen","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death\u2013a Danish nationwide cohort study. PLoS One 2013;8:e56944.","journal-title":"PLoS One"},{"key":"8348_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010;375:657\u2013663.","journal-title":"Lancet"},{"key":"8348_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/ajg.2009.81","volume":"104","author":"C Ha","year":"2009","unstructured":"Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104:1445\u20131451.","journal-title":"Am J Gastroenterol"},{"key":"8348_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cgh.2008.10.021","volume":"7","author":"I Roifman","year":"2009","unstructured":"Roifman I, Sun YC, Fedwick JP, Panaccione R et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:175\u2013182.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8348_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0003319716652031","volume":"68","author":"GC Wu","year":"2017","unstructured":"Wu GC, Leng RX, Lu Q, Fan YG, Wang DG, Ye DQ. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology 2017;68:447\u2013461.","journal-title":"Angiology"},{"key":"8348_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/CRD.0000000000000214","volume":"26","author":"MG Nevulis","year":"2018","unstructured":"Nevulis MG, Baker C, Lebovics E, Frishman WH. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Cardiol Rev 2018;26:287\u2013293.","journal-title":"Cardiol Rev"},{"key":"8348_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135\u20131143.","journal-title":"Circulation"},{"key":"8348_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","volume":"111","author":"A Lerman","year":"2005","unstructured":"Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363\u2013368.","journal-title":"Circulation"},{"key":"8348_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0961203308089988","volume":"17","author":"J Frostegard","year":"2008","unstructured":"Frostegard J. Systemic lupus erythematosus and cardiovascular disease. Lupus 2008;17:364\u2013367.","journal-title":"Lupus"},{"key":"8348_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi S, Meilahn E, Rairie J, Conte C et al. Age-specific incidence MI angina women SLE Framingham comparison. American Journal of Epidemiology 1997;145:408\u2013415.","journal-title":"American Journal of Epidemiology"},{"key":"8348_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 2015;11:693\u2013704.","journal-title":"Nat Rev Rheumatol"},{"key":"8348_CR24","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524\u20131529.","journal-title":"Ann Rheum Dis"},{"key":"8348_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132\u2013140.","journal-title":"Lancet"},{"key":"8348_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tcm.2019.10.001","volume":"30","author":"A Bigeh","year":"2020","unstructured":"Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease? Trends Cardiovasc Med 2020;30:463\u2013469.","journal-title":"Trends Cardiovasc Med"},{"key":"8348_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","volume":"145","author":"NR Cook","year":"2006","unstructured":"Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006;145:21\u201329.","journal-title":"Ann Intern Med"},{"key":"8348_CR28","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation 2020;142:e506\u2013e532.","journal-title":"Circulation"},{"key":"8348_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.atherosclerosis.2012.07.025","volume":"225","author":"SR El Khoudary","year":"2012","unstructured":"El Khoudary SR, Wildman RP, Matthews K, Thurston RC et al. Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition. Atherosclerosis 2012;225:180\u2013186.","journal-title":"Atherosclerosis"},{"key":"8348_CR30","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","volume":"54","author":"KA Matthews","year":"2009","unstructured":"Matthews KA, Crawford SL, Chae CU, Everson-Rose SA et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366\u20132373.","journal-title":"J Am Coll Cardiol"},{"key":"8348_CR31","doi-asserted-by":"crossref","unstructured":"Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of Metabolic Syndrome Severity During the Menopausal Transition. J Am Heart Assoc 2016;5.","DOI":"10.1161\/JAHA.116.003609"},{"key":"8348_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","volume":"42","author":"A Maas","year":"2021","unstructured":"Maas A, Rosano G, Cifkova R, Chieffo A et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J 2021;42:967\u2013984.","journal-title":"Eur Heart J"},{"key":"8348_CR33","doi-asserted-by":"crossref","unstructured":"Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61\u2013109.","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"8348_CR34","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","volume":"13","author":"JD Curb","year":"2003","unstructured":"Curb JD, McTiernan A, Heckbert SR, Koperberg C et al. Outcomes ascertainment and adjudication methods in the Women\u2019s Health Initiative. Ann Epidemiol 2003;13:S122\u2013S128.","journal-title":"Ann Epidemiol"},{"key":"8348_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/AOG.0b013e318265df42","volume":"120","author":"BL Sprague","year":"2012","unstructured":"Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999\u20132010. Obstet Gynecol 2012;120:595\u2013603.","journal-title":"Obstet Gynecol"},{"key":"8348_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa050613","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cook NR, Lee IM, Gordon D et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293\u20131304.","journal-title":"N Engl J Med"},{"key":"8348_CR37","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","volume":"73","author":"HK Abdelaziz","year":"2019","unstructured":"Abdelaziz HK, Saad M, Pothineni NVK, Megaly M et al. Aspirin for Primary Prevention of Cardiovascular Events. J Am Coll Cardiol 2019;73:2915\u20132929.","journal-title":"J Am Coll Cardiol"},{"key":"8348_CR38","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.2022.5207","volume":"327","author":"KW Davidson","year":"2022","unstructured":"Davidson KW, Barry MJ, Mangione M, Cabana CM et al. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. JAMA 2022;327:1577\u20131584.","journal-title":"JAMA"},{"key":"8348_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/00365521.2014.966753","volume":"50","author":"CL Kvasnovsky","year":"2015","unstructured":"Kvasnovsky CL, Aujla U, Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scand J Gastroenterol 2015;50:255\u2013263.","journal-title":"Scand J Gastroenterol"},{"key":"8348_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ibd\/izaa060","volume":"27","author":"P Patel","year":"2021","unstructured":"Patel P, Gao G, Gulotta G, Dalal S et al. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:236\u2013241.","journal-title":"Inflamm Bowel Dis"},{"key":"8348_CR41","doi-asserted-by":"crossref","unstructured":"Takeuchi K, Smale S, Premchand P, Maiden L, et al. Prevalence and mechanism of NSAID clinical relapse in IBD. Clin Gastroenterol Hepatol 2006:196\u2013202.","DOI":"10.1016\/S1542-3565(05)00980-8"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08348-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08348-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08348-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T22:04:20Z","timestamp":1721340260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08348-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["8348"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08348-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<i>Ruby Greywoode<\/i>: None. <i>Joseph Larson<\/i>: None. <i>Jellyana Peraza<\/i>: None. <i>Rachel Clark<\/i>: None. <i>Matthew A. Allison<\/i>: None. <i>Naueen A. Chaudhry<\/i>: None. <i>Peter F. Schnatz:<\/i> None. <i>Alladin H. Shadyah<\/i>: None. <i>Robert B. Wallace<\/i>: None. Sylvia <i>Wassertheil-Smoller<\/i>: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}